Assyro AI

Orange Book product · Generic (ANDA)

TELMISARTAN AND AMLODIPINE

AMLODIPINE BESYLATE; TELMISARTAN

Generic (ANDA)ANDA 202517DISCN TORRENT

At a glance

Jan 08, 2014

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 08, 2014

    12 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

AMLODIPINE BESYLATE; TELMISARTAN

Strength

EQ 5MG BASE;40MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

ANDA 202517

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of AMLODIPINE BESYLATE; TELMISARTAN

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.